This webinar will provide an overview of emerging evidence on the effectiveness of vaccinations among the care home population and will showcase two studies that are measuring COVID-19 immunity among care home populations in Canada and the UK.
Each speaker will provide an introduction to the situation in their country in relation to COVID-19 vaccinations and care home population, as well as introducing their respective studies.
The webinar will be organised around 3 key questions:
- What is the evidence on the effectiveness of COVID-19 vaccines for people living in care homes?
- What do we know about the duration of immunity?
- What are the implications of what we know so far, and what is the evidence we need in order to address the ongoing challenges posed by COVID-19 in care homes?
Jorge Browne (MD, MSc. Servicio Nacional del Adulto Mayor, Universidad Católica de Chile):
Epidemiological status of Long Term Care Facilities with high vaccination coverage and high community transmission: the case of Chile
Amy Hsu (Bruyère Research Institute and University of Ottawa Department of Family Medicine):
Initial findings from the C19 Immunity study: Identification of underlying factors influencing the immune response to SARS-CoV-2 among workers and residents in long-term care homes: a multi-province study https://www.c19immunitystudy.ca
Laura Shallcross (UCL, Institute of Health Informatics, UK):
The Vivaldi study: epidemiology of SARS-CoV2 infection amongst care home residents and staff in England: https://www.ucl.ac.uk/health-informatics/research/vivaldi-study
The webinar will last 90 minutes, with time for discussion in the last 30 minutes. The webinar will be recorded and a video will be shared afterwards.
The video and slides for this webinar are available here: